Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Clinical Nuclear Medicine|March 5, 2013
Imaging findings and therapy response monitoring in chronic sclerodermatous graft-versus-host disease: preliminary data of a simultaneous PET/MRI approachAlexander W Sauter, Holger Schmidt, Frederic Mantlik, et al.
Human Pathology|October 12, 2014
The detection of SRSF2 mutations in routinely processed bone marrow biopsies is useful in the diagnosis of chronic myelomonocytic leukemiaBirgit Federmann, Manuel Abele, David Santiago Rosero Cuesta, et al.
Bone Marrow Transplantation|April 17, 2012
Dose-escalated radioimmunotherapy as part of reduced intensity conditioning for allogeneic transplantation in patients with advanced high-grade non-Hodgkin lymphomaW A Bethge, S von Harsdorf, M Bornhauser, et al.
International Orthopaedics|November 9, 2014
Coating with a novel gentamicinpalmitate formulation prevents implant-associated osteomyelitis induced by methicillin-susceptible Staphylococcus aureus in a rat modelChristian Fölsch, Maike Federmann, Klaus D Kuehn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2014
Monocyte-induced development of Th17 cells and the release of S100 proteins are involved in the pathogenesis of graft-versus-host diseaseKatharina Reinhardt, Dirk Foell, Thomas Vogl, et al.
Annals of Hematology|March 2, 2017
Haploidentical hematopoietic cell transplantation using in vitro T cell depleted grafts as salvage therapy in patients with disease relapse after prior allogeneic transplantationSebastian P Haen, Christiane Groh, Michael Schumm, et al.
JACC. Cardiooncology|June 19, 2025
Postural Orthostatic Tachycardia Syndrome and Orthostatic Hypotension Following Hematopoietic Stem Cell TransplantationGeorgia K Thomas, Josh West, Michele Golino, et al.
Ebiomedicine|April 7, 2019
Alternative splicing of the tumor suppressor ASPP2 results in a stress-inducible, oncogenic isoform prevalent in acute leukemiaMarcus Matthias Schittenhelm, Bianca Walter, Vasileia Tsintari, et al.
Cancer Immunology Research|January 12, 2018
The Immune Checkpoint Modulator OX40 and Its Ligand OX40L in NK-Cell Immunosurveillance and Acute Myeloid LeukemiaTina Nuebling, Carla Emilia Schumacher, Martin Hofmann, et al.
Blood|April 23, 2015
High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma: a valuable tool to improve diagnostic yield of vitreous aspiratesIrina Bonzheim, Sabrina Giese, Christoph Deuter, et al.
Pageof 9